The next wave of major industrial and societal challenges to receive investment through the government’s modern Industrial Strategy have been confirmed.
The Industrial Strategy Challenge Fund brings together the UK’s world-leading research base with our best businesses to transform how we live, work and move around. It will put the UK in the best position to take advantage of future market opportunities.
The fund is delivered by UK Research and Innovation and is part of government’s £4.7 billion investment in R&D over 4 years that will support the delivery of its modern Industrial Strategy.
The details of the next wave of challenges are confirmed as below:
- Accelerating Detection of Disease
- Digital Security by Design
- Driving the Electric Revolution
- Industrial Decarbonisation
- Manufacturing Made Smarter
- Low Cost Nuclear
- Smart sustainable plastic packaging
In addition last month the Government confirmed an investment in Quantum Technologies – a £153 million Industrial Strategy Challenge Fund which will be matched by industry with over £200 million of investment expected from the private sector.
Please see this link for more information.
£100 million Rutherford Fund to attract best researchers to the UK
Future electric vehicles: new Faraday battery challenge funding
Meeting the Industrial Challenges – 8/1/18
Science Research and Innovation Policy – new calls from government










3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
Four BU students at national midwifery conference
INRC book roundtable/presentation by Drs Jonathan Cole and Catherine Talbot, Wednesday 22/04/2026, 13:00h, P426
BU M.Res. student’s evidence to UK Parliamentary Women & Equalities Committee
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease